AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Moberg Pharma

Major Shareholding Notification Mar 25, 2024

3174_iss_2024-03-25_0800c65d-33e2-4cbc-ac7a-26265c853c1a.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer Moberg Pharma AB (publ)

Holder

Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension

Instrument
------------
Instrument Aktier
Before the transaction
Shares Data not given
Data not given
Voting rights
Transaction
Reason for major shareholding notification Sell
Date 22/03/2024
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 1,410,920
Directly held voting rights 0
Indirectly held voting rights 1,410,920
Percentage
Directly held shares 4.96672 %
Directly held voting rights 0 %
Indirectly held voting rights 4.96672 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 4.96672 % 1,410,920
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled 0.30776 % 87,426
Total 5.27448 % 1,498,346

Group total holdings

Voting rights 1,498,346 Percentage of voting rights 5.27448

Notes (other relevant informations according to law)

Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt har avyttrat de aktuella aktierna.

Published

25/03/2024 10:20

Contact

Name Marie Andersson

Email [email protected]

*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.